| Reporting Segment | Product Linearrow_drop_down | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Predictive Oncology Test |
Licensing of Patents for Diagnostic Testing
These companies develop tests for diagnosing patients, and license their patented diagnostic technology to healthcare companies.
|
3.79M | 49.07% |
| Predictive Oncology Test |
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Diversified Payors
These companies operate Genetic, Genomic, and Sequencing diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. Revenue is ultimately derived from commercial insurance providers, consumers as well as medicare and medicaid.
|
1.46M | 18.89% |
| Predictive Oncology Test |
Genetic, Genomic, and Sequencing Kits (outsourced)
These companies outsource the manufacturing of genetic, genomic, and sequencing test kits and sell directly to their customers.
|
2.48M | 32.03% |
| keyboard_arrow_down |
Predictive Oncology Test
Licensing of Patents for Diagnostic Testing
|
3.79M | 49.07% |
| keyboard_arrow_right |
These companies develop tests for diagnosing patients, and license their patented diagnostic technology to healthcare companies.
|
||
| keyboard_arrow_down |
Predictive Oncology Test
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Diversified Payors
|
1.46M | 18.89% |
| keyboard_arrow_right |
These companies operate Genetic, Genomic, and Sequencing diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. Revenue is ultimately derived from commercial insurance providers, consumers as well as medicare and medicaid.
|
||
| keyboard_arrow_down |
Predictive Oncology Test
Genetic, Genomic, and Sequencing Kits (outsourced)
|
2.48M | 32.03% |
| keyboard_arrow_right |
These companies outsource the manufacturing of genetic, genomic, and sequencing test kits and sell directly to their customers.
|
||